Quarterly report [Sections 13 or 15(d)]

STOCK-BASED COMPENSATION

v3.26.3
STOCK-BASED COMPENSATION
9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION

9. STOCK-BASED COMPENSATION

 

Historically, stock options have been granted with an exercise price equal to the market value of the Common Stock on the date of grant, with expiration 10 years from the date they are granted, and generally vest over a one to four-year period for employees and members of the Board. Upon exercise, new shares will be issued by the Company. The restricted shares and restricted stock units (“RSUs”) granted to Board members and employees generally have a one to four-year graded vesting period and are subject to accelerated vesting and forfeiture under certain circumstances. For the nine months ended September 30, 2026, the Company has issued 318,554 stock options and 614,957 RSUs.

 

The following table provides the weighted average assumptions used in determining the fair value of the stock option awards granted during the nine-month period ended September 30, 2026. The exercise price for these options is $10.10.

    September 30, 2026  
       
Risk-free interest rate     4.64 %
Expected life     6.25 years  
Expected volatility     145.67 %
Dividend yield     -  

 

 

 

There were no stock option awards issued during the nine months ended September 30, 2025.

 

The grant date fair value for the RSUs that were issued was $8.05.

 

The Company recognized approximately $4.0 million and $7,000 of stock-based compensation expense within continuing operations during the three-month periods ended September 30, 2026 and 2025, respectively, and approximately $4.0 million and $31,000 for the nine-month periods ended September 30, 2026 and 2025, respectively. Of that $4.0 million, $3.8 million was related to RSUs that vested immediately upon the date of grant. The following table has a breakout of stock-based compensation expense from continuing operations by line item.

 

    2026     2025     2026     2025  
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2026     2025     2026     2025  
                         
Cost of revenue   $ 4     $ -     $ 4     $ -  
Sales and marketing     267       6       276       21  
General and administrative     3,722       1       3,721       10  
Total stock compensation expense   $ 3,993     $ 7     $ 4,001     $ 31